Repligen Corp [RGEN] stock prices are up 0.58% to $142.58 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RGEN shares have gain 14.31% over the last week, with a monthly amount glided 5.47%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Wells Fargo started tracking the stock with Overweight rating on August 28, 2024, and set its price target to $180. On June 26, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $155 on the stock. Guggenheim started tracking the stock assigning a Neutral rating. The Benchmark Company downgraded its rating to a Hold. Wells Fargo started tracking with a Overweight rating for this stock on July 20, 2023, and assigned it a price target of $185.
The stock price of Repligen Corp [RGEN] has been fluctuating between $113.50 and $211.13 over the past year. Currently, Wall Street analysts expect the stock to reach $193.86 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $142.58 at the most recent close of the market. An investor can expect a potential return of 35.97% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp [NASDAQ:RGEN] reported sales of 633.51M for trailing twelve months, representing a surge of 9.69%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is -0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 140.38 points at the first support level, and at 138.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 144.99, and for the 2nd resistance point, it is at 147.41.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp [NASDAQ:RGEN]’s Current Ratio is 10.44. As well, the Quick Ratio is 8.76, while the Cash Ratio is 7.23. Considering the valuation of this stock, the price to sales ratio is 12.68, the price to book ratio is 3.96.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Nov 21 ’24 when 24246.0 shares were sold. Executive Chairman, Anthony Hunt completed a deal on Nov 21 ’24 to buy 24246.0 shares. Meanwhile, Director Hunt Anthony sold 22191.0 shares on Sep 10 ’24.
